Harlan Laboratories Contract Research Services has established an external Scientific Advisory Board. The board will provide advice and guidance to help support client studies and to provide insight into current and future trends and developments in the CRO industry.
The advisory board is chaired by Dr. John Doe and the members are: Dr. Gerd Bode, Dr. Pascal Clayette, Dr. Cliff Elcombe, Dr. Peter Lord, Dr. Jeff Richig, Professor Tetsuo Satoh and Dr. Kendall B Wallace. Their expertise covers a range of disciplines including pharmacology, toxicology, pathology, neuropathology, paediatrics, cell and molecular toxicology, non-genotoxic carcinogenicity, immuno-toxicology, preclinical safety electrocardiography and chronic, reproductive and developmental toxicology.
“We are delighted that such esteemed industry personnel have agreed to join the Advisory Board,” said John Handley, vice president Environmental Sciences and Site Management, Harlan Laboratories CRS. “Their knowledge, expertise and experience will provide a vital additional level of support to clients, further enhancing our services and ensuring we deliver the best outcomes quickly and efficiently, as well as helping us to anticipate, identify and meet market demands and regulatory requirements.”